Search results “Evista treatment for breast cancer” for the 2018
Evista (raloxifene) Tablets
Evista (raloxifene) is used to treat and prevent osteoporosis in postmenopausal women. Evista reduces the risk of vertebral fractures in women with postmenopausal osteoporosis.
Views: 228 Lynch's Pharmacy
Evista Commercial (2008)
#XXVIII = 28 Original upload date: March 11, 2018 So very old commercial... About Raloxifene: It's used by women to prevent and treat bone loss (osteoporosis) after menopause. It slows down bone loss and helps to keep bones strong, making them less likely to break. Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive breast cancer) after menopause. Raloxifene is not an estrogen hormone, but it acts like estrogen in some parts of the body, like your bones. In other parts of the body (uterus and breasts), raloxifene acts like an estrogen blocker. It does not relieve menopause symptoms such as hot flashes. Raloxifene belongs to a class of drugs known as selective estrogen receptor modulators-SERMs. Bodybuilders fact: Raloxifene acts like an estrogen blocker. So some bodybuilders use as an reduction of estrogen that causes gyno (bodybuilder's term for gynecomastia) in the chest. As with all drugs, it also causes side effects as well. I DO NOT OWN THIS. ALL RIGHTS TO ELLI LILLY.
Views: 59 Charles Baluyot
RALOXIFENE: #1 Thing To Do RIGHT NOW If you don't want Gyno.
Click The Subscribe Button, and Hit the Notification Bell............. Formula Secrets Is Not Just About Arms & Abs. Be Alpha Today. *WARNING: DO NOT TRY THIS AT HOME This video is For Educational and Research Purposes only! The artist does believe however, that research videos do not have to be boring, or plain. The Personalities in These videos are intended to entertain viewers, while at the same time informing them on the experiences of others. Content within these videos are not to be mistaken for Medical Advice-Please Consult Your Personal Physician In Regards To Your Health* *ANY SUGGESTIONS CONTAINED WITHIN ARE DESIGNED AS A GUIDELINE, OBVIOUSLY EVERY PERSON IS DIFFERENT AND HAS DIFFERENT BACKGROUNDS AND DIFFERENT GENETIC TENDENCIES. IF YOU WOULD LIKE ADDITIONAL INFORMATION OR ANY INFORMATION CLARIFIED, YOU SHOULD CONTACT US DIRECTLY AT INFO@FORMULA-SECRETS.COM AND WE CAN ELABORATE FURTHER ON THIS SUBJECT MATTER FOR YOU* Kai is a professional. His results, and those of his top students, are not typical. Their experiences are not a guarantee you will get the same gains and body improvements. You may make more, less, or the same. Biggest Secret nobody is Doing.. That’s an easy answer right now… https://youtu.be/XWdLtczhG6Q I mean mostly only the elite are doing it right now..it’s cycling Gear. But most people are only doing small cycles, like Testosterone or Anavar… since they can’t afford to do the real cycles like Test stacked with Tren, Masteron and EQ.Hoops And they’re not really harnessing what you can really do with Home brewing. I’ve shown 1,000 competitive athletes how to do that, in the last couple of years. It’s pretty amazing and the results have blown me away. I’ll show you how to do in a step by step process. You can copy and use my formula that I've shared with my competitive athletes. Go right here. Do not miss these opportunities as you will regret it one day. https://youtu.be/XWdLtczhG6Q
Views: 3012 FormulaSecrets
Breast Cancer Surgery | Mastectomy and Lymphadenectomy | Breast Cancer awareness
www.medfreelancers.com Breast Cancer Surgery | Mastectomy and Lymphadenectomy | Breast Cancer awareness Breast cancer Specialty Oncology Symptoms Lump in a breast, change in breast shape, dimpling of the skin, fluid coming from the nipple, a newly inverted nipple, red scaly patch of skin Risk factors Female, obesity, lack of exercise, alcohol, hormone replacement therapy during menopause, ionizing radiation, early age at first menstruation, having children late or not at all, older age, prior breast cancer, family history, Klinefelter syndrome. Diagnostic method - Tissue biopsy Treatment - Surgery, radiation therapy, chemotherapy, hormonal therapy, targeted therapy Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, a newly inverted nipple, or a red or scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin. Risk factors for developing breast cancer include being female, obesity, lack of physical exercise, drinking alcohol, hormone replacement therapy during menopause, ionizing radiation, early age at first menstruation, having children late or not at all, older age, prior history of breast cancer, and family history. About 5–10% of cases are due to genes inherited from a person's parents, including BRCA1 and BRCA2 among others. Breast cancer most commonly develops in cells from the lining of milk ducts and the lobules that supply the ducts with milk. Cancers developing from the ducts are known as ductal carcinomas, while those developing from lobules are known as lobular carcinomas. In addition, there are more than 18 other sub-types of breast cancer. Some cancers, such as ductal carcinoma in situ, develop from pre-invasive lesions. The diagnosis of breast cancer is confirmed by taking a biopsy of the concerning lump.[1] Once the diagnosis is made, further tests are done to determine if the cancer has spread beyond the breast and which treatments it may respond to. The balance of benefits versus harms of breast cancer screening is controversial. A 2013 Cochrane review stated that it is unclear if mammographic screening does more good or harm. A 2009 review for the US Preventive Services Task Force found evidence of benefit in those 40 to 70 years of age, and the organization recommends screening every two years in women 50 to 74 years old. The medications tamoxifen or raloxifene may be used in an effort to prevent breast cancer in those who are at high risk of developing it. Surgical removal of both breasts is another preventative measure in some high risk women. In those who have been diagnosed with cancer, a number of treatments may be used, including surgery, radiation therapy, chemotherapy, hormonal therapy and targeted therapy. Types of surgery vary from breast-conserving surgery to mastectomy. Breast reconstruction may take place at the time of surgery or at a later date.[15] In those in whom the cancer has spread to other parts of the body, treatments are mostly aimed at improving quality of life and comfort. Outcomes for breast cancer vary depending on the cancer type, extent of disease, and person's age. Survival rates in the developed world are high, with between 80% and 90% of those alive for at least 5 years. In developing countries survival rates are poorer. Worldwide, breast cancer is the leading type of cancer in women, accounting for 25% of all cases. In 2012 it resulted in 1.68 million new cases and 522,000 deaths. It is more common in developed countries[3] and is more than 100 times more common in women than in men. https://en.wikipedia.org/wiki/Breast_cancer Please Subscribe, Like or share this Surgical Video. Thank you. Services available in Delhi and NCR Share, Support, Subscribe!!! Subscribe: https://goo.gl/MfIUV5 Youtube: https://www.youtube.com/user/medfreelancers Twitter: https://twitter.com/Surgical_Videos Facebook: https://www.facebook.com/SurgeryVideo Mobile & WhatsApp No:- +91 9910580561 E-mail :- medfreelancers@gmail.com About : MedFreelancers is a YouTube Channel, where you will find Surgical and Medical Videos with Medical Information in Hindi. You Can contact us for any help regarding medical :) -~-~~-~~~-~~-~- Please watch: "Endoscopic Septoplasty for Correction of Deformity of Septum | ENT Surgery " https://www.youtube.com/watch?v=Hwi9LcD1HcY -~-~~-~~~-~~-~-
Views: 514 MedFreelancers
SERMS- Selective ESTROGEN receptor modulators. Approval- Approved by FDA (US) as safe medicine. SERMS for PCT- Clomiphene Citrate ( CLOMID) - Raloxifene (Evista) - Tamoxifen Citrate ( NOLVADEX) What serms actually does ? - IT delivers all the benefits of Estrogen without the adverse side effects concerning it . SERMS used for muscle gain- Mupostarine -(OSTARINE- MK2866) Testolone- (RAD 140) Few more are there also. LIFE TIME - 24hrs DOSES - For 25mg per day for 4-6 weeks for bulking.(MK 2866) 12.5-15 mg per day for 4-6 weeks for cutting .(MK 2866) Anabolic property - even at low dose of 3mg Benefits- Increase lean mass gain Better Strength More Endurence Joint healing abilities Cure for muscle wasting Use for treatment of Osteoporosis Use for treatment of low bone density issue . Use for treatment of few types of breast cancer . Durable upto 6months or 24 weeks .. in using Click the link below to "SUBSCRIBE" to my channel. https://www.youtube.com/channel/UCryVyOe2qYxZhJzuzft3f8A?view_as=subscriber ***************************************************** MY CONTACT information - Facebook- https://www.facebook.com/niladri.basu1 Instagram- https://www.instagram.com/niladri_basu2005/ ****************************************************
Schizophrenia in Women - The Role of Hormones and Estrogen Modulating Agents
Estrogen is a neuroprotective agent and the estrogen protection hypothesis is implicated in the development of schizophrenia in women. In women estrogen delays the onset of schizophrenia. In the peri-menopausal period, fading estrogen secretion in vulnerable women can increase the risk of schizophrenia. The ADEPT trial showed that addition of transdermal estrogen (100 or 200 mcg) to antipsychotic therapy improved symptoms of schizophrenia. Selective estrogen receptor modulators (SERM's) such as Raloxifene exerts similar neurotransmitter effects to estradiol within the brain, while acting primarily as an estrogen antagonist in breast tissue and the endometrium. In women with refractory schizophrenia, raloxifene is a promising, well-tolerated agent that has potential application in clinical practice. Thus, schizophrenia in women has a strong hormonal basis and should be taken into account in clincial practice.
Views: 289 PsychScene Hub
Ask the Doc-Gyno problem during TRT.
Dr Rand talks about the best way to eliminate Estrogen build up causing gyro while on TRT.
Views: 2836 JayCutlerTV
Ixempra Commercial (2017)
#LXXIII = 73 About Ixabepilone: It is used to treat advanced breast cancer. It is usually given after other cancer medications have been tried without successful treatment. I DO NOT OWN THIS. ALL RIGHTS TO R-PHARM US AND MANUFACTURED BY Bristol-Myers Squibb.
Views: 44 Charles Baluyot
Subscribe to this channel: https://www.youtube.com/channel/UCKDwY2bhQtcMUZ3UFdN3Mng?sub_confirmation=1 Other Endocrinology Lectures: https://www.youtube.com/playlist?list=PLfBFwAwues0l7OpPoCazPLoOPTkRfUsRR Gynecomastia is an endocrine system disorder in which a noncancerous increase in the size of male breast tissue occurs.[3][4][a] Psychological distress may occur. The development of gynecomastia is usually associated with benign pubertal changes. However, 75% of pubertal gynecomastia cases resolve within two years of onset without treatment. In rare cases, gynecomastia has been known to occur in association with certain disease states. The pathologic causes of gynecomastia are diverse and may include Klinefelter syndrome, certain cancers, endocrine disorders, metabolic dysfunction, various medications, or may occur due to a natural decline in testosterone production. Disturbances in the endocrine system that lead to an increase in the ratio of estrogens/androgens are thought to be responsible for the development of gynecomastia. This may occur even if the levels of estrogens and androgens are both appropriate, but the ratio is altered. Diagnosis is based on signs and symptoms. Conservative management of gynecomastia is often appropriate, as the condition commonly resolves on its own. Medical treatment of gynecomastia that has persisted beyond two years is often ineffective. Medications such as aromatase inhibitors have been found to be effective in rare cases of gynecomastia from disorders such as aromatase excess syndrome or Peutz–Jeghers syndrome, but surgical removal of the excess tissue is usually required. Gynecomastia is common. Physiologic gynecomastia develops in up to 70% of adolescent boys. Newborns and adolescent males often experience temporary gynecomastia due to the influence of maternal hormones and hormonal changes during puberty, respectively. The classic feature of gynecomastia is male breast enlargement with soft, compressible, and mobile subcutaneous chest tissue palpated under the areola of the nipple in contrast to softer fatty tissue. This enlargement may occur on one side or both. Dimpling of the skin and nipple retraction are not typical features of gynecomastia. Milky discharge from the nipple is also not a typical finding, but may be seen in a gynecomastic individual with a prolactin secreting tumor. An increase in the diameter of the areola and asymmetry of chest tissue are other possible signs of gynecomastia. Males with gynecomastia may appear anxious or stressed due to concerns about the possibility of having breast cancer. The causes of common gynecomastia remain uncertain, but are thought to result from an imbalance between the actions of estrogen and androgens at the breast tissue. Breast prominence can result from enlargement of glandular breast tissue, chest adipose tissue (fat) and skin, and is typically a combination. As in females, estrogen stimulates the growth of breast tissue in males. In addition to directly stimulating male breast tissue growth, estrogens indirectly decrease secretion of testosterone by suppressing luteinizing hormone secretion, resulting in decreased testicular secretion of testosterone. Furthermore, estrogens can increase blood levels of the protein sex hormone-binding globulin (SHBG), which binds free testosterone (the active form) leading to decreased action of testosterone in male breast tissue. To diagnose gynecomastia, a thorough history and physical examination are obtained by a physician. Important aspects of the physical examination include evaluation of the male breast tissue with palpation to evaluate for breast cancer and pseudogynecomastia (male breast tissue enlargement solely due to excess fatty tissue), evaluation of penile size and development, evaluation of testicular development and an assessment for masses that raise suspicion for testicular cancer, and proper development of secondary sex characteristics such as the amount and distribution of pubic and underarm hair. Gynecomastia usually presents with bilateral involvement of the breast tissue but may occur unilaterally as well. Medical treatment of gynecomastia is most effective when done within the first two years after the start of male breast enlargement. Selective estrogen receptor modulators (SERMs) such as tamoxifen, raloxifene, and clomifene may be beneficial in the treatment of gynecomastia but are not approved by the Food and Drug Administration for use in gynecomastia. Clomifene seems to be less effective than tamoxifen or raloxifene. more: https://en.wikipedia.org/wiki/Gynecomastia